086280:KRXHyundai Glovis Co., Ltd. Analysis
Data as of 2026-03-11 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
Hyundai Glovis is trading at KRW 236,500, comfortably above its 20‑day SMA (KRW 255,250) and 50‑day SMA (KRW 240,364) but still below the 200‑day SMA (KRW 177,228), indicating short‑term softness within a longer‑term bullish framework. The RSI sits at 44.8, suggesting neither overbought nor oversold conditions, while the MACD histogram is negative and the MACD line trails the signal line, pointing to bearish momentum in the near term. Despite this, volume is increasing and the broader market sentiment is in “Extreme Greed” (77.48 on the Fear & Greed Index), supporting the overall bullish trend direction. Valuation metrics are compelling: a forward P/E of 9.3 is far below the industry average of 29.3, and the DCF‑derived fair value (KRW 231,729) is close to the current price, implying limited upside but a reasonable margin of safety. The dividend yield of 2.47% with a modest payout ratio of 20% underscores cash‑flow strength and dividend sustainability. Financially, the company posts solid ROE (15.1%) and ROA (7.5%) with a manageable debt‑to‑equity of 38.5% and a low beta of 0.56, indicating limited volatility relative to the market. Analyst consensus is bullish (Buy) with median price targets near KRW 314,500, suggesting a sizable upside potential of around 25% from current levels.
Market Outlook
Short Term
< 1 yearKey Factors
- Price below short‑term SMA20 and SMA50
- Bearish MACD histogram
- Increasing volume supporting potential rebound
Medium Term
1–3 yearsKey Factors
- Significant valuation discount to industry peers
- Strong dividend yield with low payout ratio
- Analyst price targets indicating ~25% upside
Long Term
> 3 yearsKey Factors
- Robust cash‑flow generation and stable ROE
- Low beta and moderate volatility for defensive positioning
- Growth prospects in integrated freight and logistics amid global trade recovery
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.